Skip to content
OVistoaIntelligence index
AboutMethodologyPricingDocs
Sign inSign up
BREAKINGPerson found dead in car after it plows into health club in Portland, Oregon10 min ago
Top StoriesUnited StatesCanadaWorldPoliticsGeneralBusinessTechHealthAviationSportsArtificial IntelligencePublishers

FDA expands access to pancreatic cancer drug helping patients like Ben Sasse

1 articles · 1 outlets · spread 0.00

FDA expands access to pancreatic cancer drug helping patients like Ben Sasse
health1 d ago

FDA expands access to pancreatic cancer drug helping patients like Ben Sasse

Full coverage view across outlets, lean, source quality, and framing. Compare framing without algorithmic ranking.

1 articles1 outletsSpread 0.0012 claims
OVistoa

Article-level news analysis, transparent scoring, and API tools for readers, publishers, and teams that need source context.

DMCA and copyright review

Copyright owners can submit notices, counter-notices, and source material concerns through the dedicated review flow.

Open DMCA review

Product

  • Home
  • Feed
  • Search
  • Topics
  • Saved

Platform

  • About
  • Methodology
  • Home
  • Search
  • Saved
  • Me

From the Left

0 outlets

No coverage from this perspective yet.

From the Center

1 outlet
  • CBS News·May 1

    FDA expands access to pancreatic cancer drug helping patients like Ben Sasse

    By Kerry Breen News Editor Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, breaking news and issues including substance use. Read Full Bio Updated on: May 2, 2026 / 6:11 AM EDT / CBS News Add CBS News on Google The Food and Drug Administration said it will allow some pancreatic cancer patients to receive access to a promising drug, even before it is officially approved for use. The medication, daraxonrasib, is a 300 milligram pill taken once a day. The drug blocks a signal that causes cancer cells to grow non-stop. Drugmaker Revolution Medicine reported that in a clinical trial, metastatic pancreatic cancer patients who took the drug survived a median of 13 months, compared to about six months for similar patients who underwent chemotherapy. Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" in a conversation with "60 Minutes" and said it has helped him live longer and with less pain. He was diagnosed with stage-four pancreatic cancer in December."I have much, much less pain than I had four months ago when I

From the Right

0 outlets

No coverage from this perspective yet.

Claim synthesis

Pro users see canonical claims across the cluster and which outlets reported each one.

Learn more

Outlets covering this story

CBS News

First seen

May 1, 2026

Latest

May 1, 2026

Outlets

1

Diversity

100/100

  • Pricing
  • API docs
  • Publishers

    • Account

    • Sign in
    • Create account
    • Reader settings
    • API console

    Legal

    • Terms
    • Privacy
    • Security
    • DMCA

    © 2026 Vistoa. All rights reserved.

    Limited excerpts, attribution, analysis, and outbound publisher links remain core product boundaries.